University of Dundee
University of Dundee
Dr Susan Wyllie gained her PhD at the University of Edinburgh in 1999 following studies of the parasitic bacteria, Chlamydia psittaci. Following a 3-year postdoc at the University of North Carolina (Chapel Hill), Susan joined the laboratory of Professor Alan Fairlamb at the University of Dundee to study drug target identification and characterisation in protozoan parasites. Now leading her own research group in Dundee, Susan’s research focuses on determining the mechanisms of action of drugs targeting tropical diseases. Susan and her group collaborate with drug discovery programs from around the world, providing critical information that can accelerate the development of better, more effective drugs for diseases that severely impact Low- and Middle-Income countries.
Research strategy
- Using complementary methodologies in the fields of genomics, chemical proteomics, and cell biology to determine the mechanisms of action and molecular targets of phenotypically-active compounds
- Developing new genetic and cell biology tools to study drug mechanism of action
- Functional characterisation of novel drug targets
- Developing novel cell-based assays to exploit high value drug targets
https://modeofactiondundee.org/
https://discovery.dundee.ac.uk/en/persons/susan-wyllie
https://orcid.org/0000-0001-8810-5605
Twitter: @LabWyllie